Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Pinilla-Ibarz

Fixed-Duration Venetoclax Plus Obinutuzumab Improves PFS and Minimal Residual Disease Negativity in Patients With Previously Untreated CLL and Comorbidities

Hematological Oncology

Cancer Research

English